Inhibition of autophagy potentiates the antitumor effect of the multikinase inhibitor sorafenib in hepatocellular carcinoma
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of autophagy potentiates the antitumor effect of the multikinase inhibitor sorafenib in hepatocellular carcinoma
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 131, Issue 3, Pages 548-557
Publisher
Wiley
Online
2011-08-20
DOI
10.1002/ijc.26374
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The role of TOR in autophagy regulation from yeast to plants and mammals
- (2014) Sandra Díaz-Troya et al. Autophagy
- Purification of autophagosomes from rat hepatocytes
- (2010) Per O. Seglen et al. Autophagy
- Vorinostat and sorafenib increase ER stress, autophagy and apoptosis via ceramide-dependent CD95 and PERK activation
- (2010) Margaret A. Park et al. CANCER BIOLOGY & THERAPY
- Methods in Mammalian Autophagy Research
- (2010) Noboru Mizushima et al. CELL
- The Bcl-xL inhibitor, ABT-737, efficiently induces apoptosis and suppresses growth of hepatoma cells in combination with sorafenib
- (2010) Hayato Hikita et al. HEPATOLOGY
- Drug therapy: Sorafenib
- (2010) Richard S. Finn HEPATOLOGY
- Sorafenib induces apoptosis and autophagy in prostate cancer cells in vitro
- (2010) Ullén INTERNATIONAL JOURNAL OF ONCOLOGY
- Mammalian Target of Rapamycin (mTOR): Conducting the Cellular Signaling Symphony
- (2010) Kathryn G. Foster et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Autophagy Is a Critical Mechanism for the Induction of the Antileukemic Effects of Arsenic Trioxide
- (2010) Dennis J. Goussetis et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma
- (2010) Satoshi Shimizu et al. JOURNAL OF HEPATOLOGY
- Sorafenib Activates CD95 and Promotes Autophagy and Cell Death via Src Family Kinases in Gastrointestinal Tumor Cells
- (2010) Margaret A. Park et al. MOLECULAR CANCER THERAPEUTICS
- Targeted Activation of Innate Immunity for Therapeutic Induction of Autophagy and Apoptosis in Melanoma Cells
- (2009) Damià Tormo et al. CANCER CELL
- Autophagy Is Activated by TGF- and Potentiates TGF- -Mediated Growth Inhibition in Human Hepatocellular Carcinoma Cells
- (2009) K. Kiyono et al. CANCER RESEARCH
- The Double-Edged Sword of Autophagy Modulation in Cancer
- (2009) E. White et al. CLINICAL CANCER RESEARCH
- Sorafenib inhibits signal transducer and activator of transcription-3 signaling in cholangiocarcinoma cells by activating the phosphatase shatterproof 2
- (2009) Boris R. A. Blechacz et al. HEPATOLOGY
- An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1
- (2009) Carson C. Thoreen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Association of Autophagy Defect with a Malignant Phenotype and Poor Prognosis of Hepatocellular Carcinoma
- (2008) Z.-B. Ding et al. CANCER RESEARCH
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started